Infused CD34+ cell dose predicts response to stem cell boost in children with poor graft function following allogeneic hematopoietic stem cell transplantation: a multicenter study from the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT

10.1038/s41409-024-02248-9 · 2024

Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT

10.1038/s41409-024-02251-0 · 2024

Graft failure in the modern era of allogeneic hematopoietic SCT

10.1038/bmt.2012.239 · 2012

Association of an Impaired Bone Marrow Microenvironment with Secondary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

10.1016/j.bbmt.2013.07.014 · 2013

Graft Failure

2024

Poor graft function after allogeneic hematopoietic stem cell transplantation—an old complication with new insights☆

10.1053/j.seminhematol.2018.08.004 · 2019

Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation

10.1177/2040620720948743 · 2020

10.1016/j.jtct.2021.04.007

10.1016/j.jtct.2021.04.007 · 2021

Graft Failure after Allogeneic Hematopoietic Cell Transplantation

10.1016/j.bbmt.2007.10.025 · 2008

Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

10.1016/j.jtct.2021.07.012 · 2021

Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation

10.1080/10428194.2021.1872072 · 2021

Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

10.1016/j.bbmt.2019.05.036 · 2019

Definitions, incidence and outcome of poor graft function after hematopoietic cell transplantation: A systematic review and meta-analysis

10.1016/j.blre.2023.101076 · 2023

Clinical features, pathophysiology, and therapy of poor graft function post–allogeneic stem cell transplantation

10.1182/bloodadvances.2021004537 · 2022

Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation

10.1007/s00277-019-03715-w · 2019

Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant

10.1080/10428194.2020.1789622 · 2020

Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis

10.1038/bmt.2016.98 · 2016

Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients

10.1016/s0301-472x(99)00076-4 · 1999

Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation

10.3389/fimmu.2022.911174 · 2022

Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies

10.1016/s1473-3099(25)00069-6 · 2025

Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation

10.1002/hem3.70059 · 2024

Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders

10.1038/sj.bmt.1705072 · 2005

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant

10.1016/j.bbmt.2019.05.023 · 2019

CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation

10.1111/bjh.15012 · 2018

Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study

10.3727/096368912x661319 · 2014

Outcomes Following Second Allogeneic Stem Cell Transplant for Graft Failure or Poor Graft Function: A Single Centre Experience

10.1007/s12015-025-10903-x · 2025

Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation

10.1038/sj.bmt.1705760 · 2007

CD34+-Selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies

10.1016/j.bbmt.2013.11.034 · 2014

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function

10.3324/haematol.2019.226340 · 2020

CD34+-selected stem cell “Boost” for poor graft function after allogeneic hematopoietic stem cell transplantation

2019

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Th…

10.1016/j.jtct.2021.04.007 · 2021

Documentation of Engraftment and Chimerism After HCT

2024

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

10.1016/j.bbmt.2015.09.001 · 2016

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

10.1016/j.bbmt.2014.12.001 · 2015

CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation

10.1016/j.bbmt.2014.05.016 · 2014

Autoimmune neutropenia: a rare complication of allogeneic hematopoietic stem cell transplantation?

10.3389/fimmu.2025.1640546 · 2025

Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transpla…

10.1016/j.jtct.2024.03.019 · 2024

CD34+-selected stem cell “Boost” for poor graft function after allogeneic hematopoietic stem cell transplantation

2019

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function

10.3324/haematol.2019.226340 · 2020

CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective multicenter study

10.1111/petr.13909 · 2021

CD3+TCRαβ/CD19+-depleted stem cell boost and CD45RO+ memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT

10.1002/pbc.31203 · doi-reference

Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience

10.3389/fped.2024.1375493 · doi-reference

Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis

10.3389/fimmu.2023.1106464 · doi-reference

Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model

10.1186/s13287-015-0155-5 · doi-reference

Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study

10.1007/s12185-021-03153-3 · doi-reference

Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children

10.1111/petr.14010 · doi-reference

Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: Guidelines from the american society for blood and marrow transplantation

10.1016/j.bbmt.2014.05.003 · doi-reference

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: Consensus guidelines and recommendations

10.1016/j.bbmt.2013.10.013 · doi-reference